AU2002232606A1 - Method and apparatus for treating breakthrough pain - Google Patents

Method and apparatus for treating breakthrough pain

Info

Publication number
AU2002232606A1
AU2002232606A1 AU2002232606A AU3260602A AU2002232606A1 AU 2002232606 A1 AU2002232606 A1 AU 2002232606A1 AU 2002232606 A AU2002232606 A AU 2002232606A AU 3260602 A AU3260602 A AU 3260602A AU 2002232606 A1 AU2002232606 A1 AU 2002232606A1
Authority
AU
Australia
Prior art keywords
breakthrough pain
treating breakthrough
treating
pain
breakthrough
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002232606A
Inventor
Dennis Coleman
Steven A Shoemaker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cephalon LLC
Original Assignee
Cephalon LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cephalon LLC filed Critical Cephalon LLC
Publication of AU2002232606A1 publication Critical patent/AU2002232606A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
AU2002232606A 2000-12-11 2001-12-11 Method and apparatus for treating breakthrough pain Abandoned AU2002232606A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US25462700P 2000-12-11 2000-12-11
US60/254,627 2000-12-11
US10/013,266 US20020106407A1 (en) 2000-12-11 2001-12-10 Method and apparatus for treating breakthrough pain
US10/013,266 2001-12-10
PCT/US2001/048584 WO2002047688A2 (en) 2000-12-11 2001-12-11 Method and apparatus for treating breakthrough pain

Publications (1)

Publication Number Publication Date
AU2002232606A1 true AU2002232606A1 (en) 2002-06-24

Family

ID=26684628

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002232606A Abandoned AU2002232606A1 (en) 2000-12-11 2001-12-11 Method and apparatus for treating breakthrough pain

Country Status (7)

Country Link
US (1) US20020106407A1 (en)
EP (1) EP1368033A2 (en)
JP (1) JP2004536031A (en)
AU (1) AU2002232606A1 (en)
CA (1) CA2431287A1 (en)
MX (1) MXPA03005189A (en)
WO (1) WO2002047688A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002009707A1 (en) 2000-07-31 2002-02-07 Nycomed Danmark A/S Fentanyl composition for nasal administration
DE10141650C1 (en) 2001-08-24 2002-11-28 Lohmann Therapie Syst Lts Safe transdermal therapeutic system for administration of fentanyl or analogous analgesics, having matrix layer of carboxy group-free polyacrylate adhesive providing high permeation rate
KR20050096950A (en) * 2003-01-31 2005-10-06 오렉쏘 에이비 A rapid-acting pharmaceutical composition
US20040253307A1 (en) * 2003-02-04 2004-12-16 Brian Hague Sugar-free oral transmucosal solid dosage forms and uses thereof
KR20060054346A (en) * 2003-07-25 2006-05-22 유로-셀띠끄 소시에떼 아노님 Preoperative treatment of post operative pain
US20050065175A1 (en) * 2003-09-24 2005-03-24 Xanodyne Pharmacal, Inc. Oral transmucosal methadone
DE202006018609U1 (en) 2006-08-29 2007-05-16 Euro-Celtique S.A. Needle-free apparatus for administrating pharmaceutical composition in humans, comprises a housing; auxiliary substance to force a pharmaceutical composition from a package into human body; a composition comprising analgesic, e.g. opioids
US9662274B2 (en) * 2014-04-11 2017-05-30 Innovative Products, Inc. Method of orally administering a treating agent over an extended period
US9650338B1 (en) 2016-07-29 2017-05-16 VDM Biochemicals, Inc. Opioid antagonist compounds and methods of making and using

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4863737A (en) * 1985-05-01 1989-09-05 University Of Utah Compositions and methods of manufacture of compressed powder medicaments
US5855908A (en) * 1984-05-01 1999-01-05 University Of Utah Research Foundation Non-dissolvable drug-containing dosage-forms for use in the transmucosal delivery of a drug to a patient
US5288498A (en) * 1985-05-01 1994-02-22 University Of Utah Research Foundation Compositions of oral nondissolvable matrixes for transmucosal administration of medicaments
US5132114A (en) * 1985-05-01 1992-07-21 University Of Utah Research Foundation Compositions and methods of manufacture of compressed powder medicaments
US5122127A (en) * 1985-05-01 1992-06-16 University Of Utah Apparatus and methods for use in administering medicaments by direct medicament contact to mucosal tissues
US5785989A (en) * 1985-05-01 1998-07-28 University Utah Research Foundation Compositions and methods of manufacturing of oral dissolvable medicaments
US5783207A (en) * 1985-05-01 1998-07-21 University Of Utah Research Foundation Selectively removable nicotine-containing dosage form for use in the transmucosal delivery of nicotine
US5288497A (en) * 1985-05-01 1994-02-22 The University Of Utah Compositions of oral dissolvable medicaments
US4671953A (en) * 1985-05-01 1987-06-09 University Of Utah Research Foundation Methods and compositions for noninvasive administration of sedatives, analgesics, and anesthetics
US4885173A (en) * 1985-05-01 1989-12-05 University Of Utah Methods and compositions for noninvasive dose-to-effect administration of drugs with cardiovascular or renal vascular activities
US5824334A (en) * 1989-09-05 1998-10-20 University Of Utah Research Foundation Tobacco substitute
US5543434A (en) * 1994-02-25 1996-08-06 Weg; Stuart L. Nasal administration of ketamine to manage pain
WO1995031182A1 (en) * 1994-05-13 1995-11-23 Aradigm Corporation Narcotic containing aerosol formulation
US20020006438A1 (en) * 1998-09-25 2002-01-17 Benjamin Oshlack Sustained release hydromorphone formulations exhibiting bimodal characteristics
US6284266B1 (en) * 1995-07-28 2001-09-04 Zars, Inc. Methods and apparatus for improved administration of fentanyl and sufentanil
US6245347B1 (en) * 1995-07-28 2001-06-12 Zars, Inc. Methods and apparatus for improved administration of pharmaceutically active compounds
US5658583A (en) * 1995-07-28 1997-08-19 Zhang; Jie Apparatus and methods for improved noninvasive dermal administration of pharmaceuticals
US5968547A (en) * 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
SE9803240D0 (en) * 1998-09-24 1998-09-24 Diabact Ab A pharmaceutical composition having a rapid action
GB9904911D0 (en) * 1999-03-03 1999-04-28 Scherer Ltd R P Pharmaceutical compositions
US6319510B1 (en) * 1999-04-20 2001-11-20 Alayne Yates Gum pad for delivery of medication to mucosal tissues
AU5169200A (en) * 1999-06-16 2001-01-02 Nastech Pharmaceutical Co., Inc. Methods and compositions for treating breakthrough pain
US6261595B1 (en) * 2000-02-29 2001-07-17 Zars, Inc. Transdermal drug patch with attached pocket for controlled heating device
WO2002009707A1 (en) * 2000-07-31 2002-02-07 Nycomed Danmark A/S Fentanyl composition for nasal administration

Also Published As

Publication number Publication date
US20020106407A1 (en) 2002-08-08
MXPA03005189A (en) 2004-03-26
WO2002047688A3 (en) 2003-03-20
WO2002047688A2 (en) 2002-06-20
EP1368033A2 (en) 2003-12-10
JP2004536031A (en) 2004-12-02
CA2431287A1 (en) 2002-06-20

Similar Documents

Publication Publication Date Title
IL157684A0 (en) Apparatus and method for photocosmetic and photodermatological treatment
EP1361604A4 (en) Device and method for treatment
HK1042812B (en) Plasma treatment apparatus and plasma treatment method
AU2001294598A1 (en) Tissue treatment method and apparatus
EP1411849A4 (en) Apparatus and methods for treating tissue
IL160505A0 (en) Method and apparatus for acne treatment
HUP0302014A3 (en) Method and device for process controlling
AU2001266958A1 (en) Method and apparatus for stimulating neurogical tissue
IL155887A0 (en) Improved hemodialysis treatment apparatus and method
AU2001257069A1 (en) Photostimulaton treatment apparatus and methods for use
AU2001289041A1 (en) Method and apparatus for treating wastewater
AU2000233489A1 (en) Methods and apparatus for treating waste
EP1152646A4 (en) Method and apparatus for plasma treatment
GB2364622B (en) Sterilisation apparatus and method
AU2001229471A1 (en) Apparatus and method for hair treatment
AU2002232606A1 (en) Method and apparatus for treating breakthrough pain
GB9807944D0 (en) Apparatus for wastewater treatment and method
AUPQ793100A0 (en) Improved chemical treatment methods and apparatus
ZA200401528B (en) Method and apparatus for acne treatment
DZ3314A1 (en) Method and device for effluent treatment
GB0004579D0 (en) Apparatus and method for water treatment
AU2001212971A1 (en) Apparatus and method for intrabodily treatment
AU1068701A (en) Method and apparatus for treating fluids
AU5169200A (en) Methods and compositions for treating breakthrough pain
EP1246900A4 (en) Method and apparatus for tissue treatment